These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21240036)

  • 1. Photoreceptor reconstitution correlates with visual improvement after intravitreal bevacizumab treatment of choroidal neovascularization secondary to traumatic choroidal rupture.
    Francis JH; Freund KB
    Retina; 2011 Feb; 31(2):422-4. PubMed ID: 21240036
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing ranibizumab with bevacizumab.
    Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
    Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture.
    Chanana B; Azad RV; Kumar N
    Eye (Lond); 2009 Nov; 23(11):2125-6. PubMed ID: 19169235
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
    Derriman L; Marshall J; Moorman C; Downes SM
    Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
    [No Abstract]   [Full Text] [Related]  

  • 5. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
    Acta Ophthalmol; 2012 Feb; 90(1):e82-3. PubMed ID: 21470378
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
    Laud K; Spaide RF; Freund KB; Slakter J; Klancnik JM
    Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
    Spandau UH; Jonas JB
    Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
    [No Abstract]   [Full Text] [Related]  

  • 10. Myopic choroidal neovascularization.
    Ruiz-Moreno JM; López-Gálvez MI; Donate J; Gomez-Ulla F; García-Arumí J; García-Layana A; Sellés I; Reche J; Montero JA; Pazos B; Zapata MA; Pastor JC
    Ophthalmology; 2011 Dec; 118(12):2521-3. PubMed ID: 22136676
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
    Mavrakanas N; Mendrinos E; Tabatabay C; Pournaras CJ
    Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
    [No Abstract]   [Full Text] [Related]  

  • 12. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
    Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
    Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F; Eid Farah M; Melo GB
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
    Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
    Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child.
    Piermarocchi S; Benetti E; Fracasso G
    J AAPOS; 2011 Jun; 15(3):314-6. PubMed ID: 21665504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.
    Tewari A; Dhalla MS; Apte RS
    Retina; 2006; 26(9):1093-4. PubMed ID: 17151505
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
    Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A; Moraes N; Farah ME; Bonomo PP
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.